{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:42:51Z","timestamp":1794256971622,"version":"4.9.0"},"reference-count":152,"publisher":"Bentham Science Publishers Ltd.","issue":"31","funder":[{"DOI":"10.13039\/501100002850","name":"FONDECYT National Fund for Scientific and Technological Development","doi-asserted-by":"publisher","award":["11140174"],"award-info":[{"award-number":["11140174"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,9,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Non-Alcoholic Fatty Liver Disease (NAFLD) is characterized by abnormal\nhepatic accumulation of triacylglycerides in the absence of alcohol consumption, in association with\nOxidative Stress (OS), a pro-inflammatory state and Insulin Resistance (IR), which are attenuated by\nn-3 long-chain polyunsaturated Fatty Acids (FAs) C20-C22 (LCPUFAs) supplementation. Main\ncauses of NAFLD comprise high caloric intake and a sedentary lifestyle, with high intakes of saturated\nFAs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The review includes several searches considering the effects of n-3 LCPUFAs in NAFLD\nin vivo and in vitro models, using the PubMed database from the National Library of Medicine-\nNational Institutes of Health.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The LCPUFAs eicosapentaenoic acid (C20:5 n-3, EPA) and docosahexaenoic acid (C22:6 n-\n3, DHA) have a positive effect in diminishing liver steatosis, OS, and the levels of aspartate\naminotransferase, alanine aminotransferase and pro-inflammatory cytokines, with improvement of\ninsulin sensitivity and adiponectin levels. The molecular pathways described for n-3 LCPUFAs in\ncellular and animal models and humans include peroxisome proliferator\u2013activated receptor-\u03b1 activation\nfavouring FA oxidation, diminution of lipogenesis due to sterol responsive element binding\nprotein-1c downregulation and inflammation resolution. Besides, nuclear factor erythroid-2-related\nfactor-2 activation is elicited by n-3 LCPUFA-derived oxidation products producing direct and indirect\nantioxidant responses, with concomitant anti-fibrogenic action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The discussed effects of n-3 LCPUFA supplementation support its use in NAFLD,\nalthough having a limited value in NASH, a contention that may involve n-3 LCPUFA oxygenated\nderivatives. Clinical trials establishing optimal dosages, intervention times, type of patients and\npossible synergies with other natural products are needed in future studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190410121716","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T18:51:51Z","timestamp":1592247111000},"page":"5250-5272","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease"],"prefix":"10.2174","volume":"27","author":[{"given":"Rodrigo","family":"Valenzuela","sequence":"first","affiliation":[{"name":"Department of Nutrition, Faculty of Medicine, University of Chile, Av. Independencia 1027, Independencia, Santiago 8380453, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Nutrition and Dietetics School, Faculty of Health Sciences, Catholic University of Maule, Merced 333, Curic\u00f3 3340000, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Catalina","family":"Hern\u00e1ndez-Rodas","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Faculty of Medicine, University of Chile, Av. Independencia 1027, Independencia, Santiago 8380453, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Echeverr\u00eda","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Faculty of Medicine, University of Chile, Av. Independencia 1027, Independencia, Santiago 8380453, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Videla","sequence":"additional","affiliation":[{"name":"Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Av. Independencia 1027, Independencia, Santiago 8380453, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hep.29721","volume":"68(1)","author":"Younossi, Z.M.","year":"2018","unstructured":"Younossi, Z.M.; Loomba,R.; Anstee, Q.M.; Rinella, M.E.; Bugianesi,E.; Marchesini,G.; Neuschwander-Tetri, B.A.; Serfaty,L.; Negro,F.; Caldwell, S.H.; Ratziu,V.; Corey, K.E.; Friedman, S.L.; Abdelmalek, M.F.; Harrison, S.A.; Sanyal, A.J.; Lavine, J.E.; Mathurin,P.; Charlton, M.R.; Goodman, Z.D.; Chalasani, N.P.; Kowdley, K.V.; George,J.; Lindor, K. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018,68(1),349-360. http:\/\/dx.doi.org\/10.1002\/hep.29721 PMID: 29222917","journal-title":"Hepatology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5306\/wjco.v8.i6.429","volume":"8(6)","author":"Said,A.","year":"2017","unstructured":"Said,A.; Ghufran, A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J. Clin. On-col. 2017,8(6),429-436. http:\/\/dx.doi.org\/10.5306\/wjco.v8.i6.429 PMID: 29291167","journal-title":"World J.Clin.On-col"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35(3)","author":"Sberna, A.L.","year":"2018","unstructured":"Sberna, A.L.; Bouillet,B.; Rouland,A.; Brindisi, M.C.; Nguyen,A.; Mou-illot,T.; Duvillard,L.; Denimal,D.; Lof-froy,R.; Verg\u00e8s,B.; Hillon,P.; Petit, J.M. European Asso-ciation for the Study of the Liver (EASL),European Asso-ciation for the Study of Diabetes (EASD)  and European Association for the Study of Obesity (EASO) . Clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with type 2 diabetes. Diabet. Med. 2018,35(3),368-375. http:\/\/dx.doi.org\/10.1111\/dme.13565 PMID: 29247558","journal-title":"Clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with type 2 diabetes.Diabet.Med"},{"key":"ref=4","author":"Araya,J.","unstructured":"Araya,J.; Rodrigo,R.; Videla, L.A.; Thielemann,L.; Orel-lana,M.; Pettinelli,P.; Poniachik, J. Increase in long-chain polyunsaturated fatty acid n-6\/n-3 ratio in relation to he-patic steatosis in patients with non-alcoholic fatty liver dis-ease. Clin. Sci. (Lond.),2004,106(6),635-643. http:\/\/dx.doi.org\/10.1042\/CS20030326 PMID: 14720121","journal-title":"Clin.Sci.(Lond.)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.plipres.2011.06.003","volume":"50(4)","author":"Poudyal,H.","year":"2011","unstructured":"Poudyal,H.; Panchal, S.K.; Diwan,V.; Brown, L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog. Lipid Res. 2011,50(4),372-387. http:\/\/dx.doi.org\/10.1016\/j.plipres.2011.06.003 PMID: 21762726","journal-title":"Prog.Lipid Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.plipres.2009.07.002","volume":"48(6)","author":"Barcel\u00f3-Coblijn,G.","year":"2009","unstructured":"Barcel\u00f3-Coblijn,G.; Murphy, E.J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog. Lipid Res. 2009,48(6),355-374. http:\/\/dx.doi.org\/10.1016\/j.plipres.2009.07.002 PMID: 19619583","journal-title":"Prog.Lipid Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.plefa.2016.02.002","volume":"111","author":"Rinc\u00f3n-Cervera, M.A.","year":"2016","unstructured":"Rinc\u00f3n-Cervera, M.A.; Valenzuela,R.; Hernandez-Rodas, M.C.; Barrera,C.; Espinosa,A.; Marambio,M.; Valen-zuela, A. Vegetable oils rich in alpha linolenic acid incre-ment hepatic n-3 LCPUFA, modulating the fatty acid me-tabolism and antioxidant response in rats. Prostaglandins Leukot. Essent. Fatty Acids. 2016,111,25-35. http:\/\/dx.doi.org\/10.1016\/j.plefa.2016.02.002 PMID: 26995676","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbalip.2016.05.014","volume":"1861(9 Pt A)","author":"Metherel, A.H.","year":"2016","unstructured":"Metherel, A.H.; Domenichiello, A.F.; Kitson, A.P.; Hop-perton, K.E.; Bazinet, R.P. Whole-body DHA synthesis-secretion kinetics from plasma eicosapentaenoic acid and alpha-linolenic acid in the free-living rat. Biochim. Bio-phys. Acta. 2016,1861(9 Pt A),997-1004. http:\/\/dx.doi.org\/10.1016\/j.bbalip.2016.05.014 PMID: 27263420","journal-title":"Biochim.Bio-phys.Acta"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev.nutr.24.121803.063211","volume":"24","author":"Nakamura, M.T.","year":"2004","unstructured":"Nakamura, M.T.; Nara, T.Y. Structure, function and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 2004,24,345-376. http:\/\/dx.doi.org\/10.1146\/annurev.nutr.24.121803.063211 PMID: 15189125","journal-title":"Annu.Rev.Nutr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.plefa.2015.04.002","volume":"98","author":"Valenzuela,R.","year":"2015","unstructured":"Valenzuela,R.; Barrera,C.; Espinosa,A.; Llanos,P.; Orel-lana,P.; Videla, L.A. Reduction in the desaturation capac-ity of the liver in mice subjected to high fat diet: relation to LCPUFA depletion in liver and extrahepatic tissues. Pros-taglandins Leukot. Essent. Fatty Acids. 2015,98,7-14. http:\/\/dx.doi.org\/10.1016\/j.plefa.2015.04.002 PMID: 25910408","journal-title":"Pros-taglandins Leukot.Essent.Fatty Acids"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"64.","DOI":"10.1186\/s12944-017-0450-5","volume":"16(1)","author":"Valenzuela,R.","year":"2017","unstructured":"Valenzuela,R.; Echeverria,F.; Ortiz,M.; Rinc\u00f3n-Cervera, M.A.; Espinosa,A.; Hernandez-Rodas, M.C.; Illesca,P.; Valenzuela,A.; Videla, L.A. Hydroxytyrosol prevents re-duction in liver activity of ?-5 and ?-6 desaturases, oxida-tive stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice. Lipids Health Dis. 2017,16(1),64. http:\/\/dx.doi.org\/10.1186\/s12944-017-0450-5 PMID: 28395666","journal-title":"Lipids Health Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nut.2017.07.007","volume":"45","author":"Valenzuela,R.","year":"2018","unstructured":"Valenzuela,R.; Rinc\u00f3n-Cervera, M.A.; Echeverr\u00eda,F.; Barrera,C.; Espinosa,A.; Hern\u00e1ndez-Rodas, M.C.; Ortiz,M.; Valenzuela,A.; Videla, L.A. Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthe-sis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues. Nutrition. 2018,45,49-58. http:\/\/dx.doi.org\/10.1016\/j.nut.2017.07.007 PMID: 29129237","journal-title":"Nutrition"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.plefa.2010.02.015","volume":"82(4-6)","author":"Rapoport, S.I.","year":"2010","unstructured":"Rapoport, S.I.; Igarashi,M.; Gao, F. Quantitative contribu-tions of diet and liver synthesis to docosahexaenoic acid homeostasis. Prostaglandins Leukot. Essent. Fatty Acids. 2010,82(4-6),273-276. http:\/\/dx.doi.org\/10.1016\/j.plefa.2010.02.015 PMID: 20226642","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.nut.2016.04.006","volume":"32(11-12)","author":"Rinc\u00f3n-Cervera, M.A.","year":"2016","unstructured":"Rinc\u00f3n-Cervera, M.A.; Valenzuela,R.; Hernandez-Rodas, M.C.; Marambio,M.; Espinosa,A.; Mayer,S.; Romero,N.; Barrera M Sc,C.; Valenzuela,A.; Videla, L.A.; Videla, L.A.; Videla, L.A. Supplementation with antioxidant-rich extra virgin olive oil prevents hepatic oxidative stress and reduction of desaturation capacity in mice fed a high-fat diet: effects on fatty acid composition in liver and extrahe-patic tissues. Nutrition. 2016,32(11-12),1254-1267. http:\/\/dx.doi.org\/10.1016\/j.nut.2016.04.006 PMID: 27346714","journal-title":"Nutrition"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"107434.","DOI":"10.1155\/2012\/107434","volume":"2012","author":"Videla, L.A.","year":"2012","unstructured":"Videla, L.A.; Pettinelli, P. Misregulation of PPAR func-tioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity. PPAR Res. 2012,2012,107434. http:\/\/dx.doi.org\/10.1155\/2012\/107434 PMID: 23304111","journal-title":"PPAR Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jc.2010-2129","volume":"96(5)","author":"Pettinelli,P.","year":"2011","unstructured":"Pettinelli,P.; Videla, L.A. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an addi-tional reinforcing lipogenic mechanism to SREBP-1c in-duction, J. Clin. Endocrinol. Metab. 2011,96(5),1424-1430. http:\/\/dx.doi.org\/10.1210\/jc.2010-2129 PMID: 21325464","journal-title":"Clin.Endocrinol.Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/hep.29246","volume":"66(2)","author":"Stiede,K.","year":"2017","unstructured":"Stiede,K.; Miao,W.; Blanchette, H.S.; Beysen,C.; Harri-man,G.; Harwood, H.J. Jr; Kelley,H.; Kapeller,R.; Schmalbach,T.; Westlin, W.F. Acetyl-coenzyme A car-boxylase inhib ition reduces de novo lipogenesis in over-weight male subjects: a randomized, double-blind, cross-over study. Hepatology. 2017,66(2),324-334. http:\/\/dx.doi.org\/10.1002\/hep.29246 PMID: 28470676","journal-title":"Hepatology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.plipres.2010.05.003","volume":"49(4)","author":"Gormaz, J.G.","year":"2010","unstructured":"Gormaz, J.G.; Rodrigo,R.; Videla, L.A.; Beems, M. Bio-synthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. Prog. Lipid Res. 2010,49(4),407-419. http:\/\/dx.doi.org\/10.1016\/j.plipres.2010.05.003 PMID: 20553760","journal-title":"Prog.Lipid Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2004.06.033","volume":"37(9)","author":"Videla, L.A.","year":"2004","unstructured":"Videla, L.A.; Rodrigo,R.; Araya,J.; Poniachik, J. Oxida-tive stress and depletion of hepatic long-chain polyunsatu-rated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2004,37(9),1499-1507. http:\/\/dx.doi.org\/10.1016\/j.freeradbiomed.2004.06.033 PMID: 15454290","journal-title":"Free Radic.Biol.Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e46400.","DOI":"10.1371\/journal.pone.0046400","volume":"7(10)","author":"Valenzuela,R.","year":"2012","unstructured":"Valenzuela,R.; Espinosa,A.; Gonz\u00e1lez-Ma\u00f1\u00e1n,D.; D\u2019Espessailles,A.; Fern\u00e1ndez,V.; Videla, L.A.; Tapia, G. N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat in-duced steatosis. PLoS One. 2012,7(10),e46400. http:\/\/dx.doi.org\/10.1371\/journal.pone.0046400 PMID: 23082120","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.plefa.2016.10.001","volume":"114","author":"Echeverr\u00eda,F.","year":"2016","unstructured":"Echeverr\u00eda,F.; Ortiz,M.; Valenzuela,R.; Videla, L.A. Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: relationship to tissue development and aging. Prostaglandins Leukot. Essent. Fatty Acids. 2016,114,28-34. http:\/\/dx.doi.org\/10.1016\/j.plefa.2016.10.001 PMID: 27926461","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109(9)","author":"Horton, J.D.","year":"2002","unstructured":"Horton, J.D.; Goldstein, J.L.; Brown, M.S. SREBPs: acti-vators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest. 2002,109(9),1125-1131. http:\/\/dx.doi.org\/10.1172\/JCI0215593 PMID: 11994399","journal-title":"Clin.Invest"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.plefa.2009.05.020","volume":"81(2-3)","author":"Le, H.D.","year":"2009","unstructured":"Le, H.D.; Meisel, J.A.; de Meijer, V.E.; Gura, K.M.; Puder, M. The essentiality of arachidonic acid and docosahex-aenoic acid. Prostaglandins Leukot. Essent. Fatty Acids. 2009,81(2-3),165-170. http:\/\/dx.doi.org\/10.1016\/j.plefa.2009.05.020 PMID: 19540099","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1039\/C5FO01086A","volume":"7(1)","author":"Valenzuela,R.","year":"2016","unstructured":"Valenzuela,R.; Espinosa,A.; Llanos,P.; Hernandez-Rodas, M.C.; Barrera,C.; Vergara,D.; Romero,N.; P\u00e9rez,F.; Ruz,M.; Videla, L.A. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. Food Funct. 2016,7(1),140-150. http:\/\/dx.doi.org\/10.1039\/C5FO01086A PMID: 26471014","journal-title":"Food Funct"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jada.2011.10.007","volume":"112(3)","author":"McCarthy, E.M.","year":"2012","unstructured":"McCarthy, E.M.; Rinella, M.E. The role of diet and nutrient composition in nonalcoholic fatty liver disease, J. Acad. Nutr. Diet. 2012,112(3),401-409. http:\/\/dx.doi.org\/10.1016\/j.jada.2011.10.007 PMID: 22717200","journal-title":"Acad.Nutr.Diet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jand.2014.01.009","volume":"114(8)","author":"Da,Silva.","year":"2014","unstructured":"Da Silva, H.E.; Arendt, B.M.; Noureldin, S.A.; Therapon-dos,G.; Guindi,M.; Allard, J.P. A cross-sectional study as-sessing dietary intake and physical activity in Canadian pa-tients with nonalcoholic fatty liver disease vs. healthy con-trols, J. Acad. Nutr. Diet. 2014,114(8),1181-1194. http:\/\/dx.doi.org\/10.1016\/j.jand.2014.01.009 PMID: 24631112","journal-title":"J.Acad.Nutr.Diet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e10939.","DOI":"10.5812\/hepatmon.10939","volume":"14(2)","author":"Hashemi,Kani,A.;,Alavian.","year":"2014","unstructured":"Hashemi Kani,A.; Alavian, S.M.; Haghighatdoost,F.; Azadbakht, L. Diet macronutrients composition in nonal-coholic fatty liver disease: a review on the related docu-ments. Hepat. Mon. 2014,14(2),e10939. http:\/\/dx.doi.org\/10.5812\/hepatmon.10939 PMID: 24693306","journal-title":"Hepat.Mon"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2036.2009.04230.x","volume":"31(7)","author":"Masterton, G.S.","year":"2010","unstructured":"Masterton, G.S.; Plevris, J.N.; Hayes, P.C. Review article: omega-3 fatty acids-a promising novel therapy for non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2010,31(7),679-692. http:\/\/dx.doi.org\/10.1111\/j.1365-2036.2009.04230.x PMID: 20415840","journal-title":"Aliment.Pharmacol.Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","volume":"47(5)","author":"Zelber-Sagi,S.","year":"2007","unstructured":"Zelber-Sagi,S.; Nitzan-Kaluski,D.; Goldsmith,R.; Webb,M.; Blendis,L.; Halpern,Z.; Oren, R. Long term nutri-tional intake and the risk for non-alcoholic fatty liver dis-ease (NAFLD): a population based study, J. Hepatol. 2007,47(5),711-717. http:\/\/dx.doi.org\/10.1016\/j.jhep.2007.06.020 PMID: 17850914","journal-title":"Hepatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.3390\/nu6114691","volume":"6(11)","author":"Yang,M.","year":"2014","unstructured":"Yang,M.; Gong,S.; Ye, S.Q.; Lyman,B.; Geng,L.; Chen,P.; Li, D.Y. Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients. 2014,6(11),4691-4705. http:\/\/dx.doi.org\/10.3390\/nu6114691 PMID: 25353664","journal-title":"Nutrients"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/oby.2009.379","volume":"18(7)","author":"Araya,J.","year":"2010","unstructured":"Araya,J.; Rodrigo,R.; Pettinelli,P.; Araya, A.V.; Ponia-chik,J.; Videla, L.A. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring). 2010,18(7),1460-1463. http:\/\/dx.doi.org\/10.1038\/oby.2009.379 PMID: 19875987","journal-title":"Obesity (Silver Spring)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"981.","DOI":"10.3390\/nu9090981","volume":"9(9)","author":"Ter,Horst.","year":"2017","unstructured":"Ter Horst, K.W.; Serlie, M.J. Fructose consumption, lipo-genesis and non-alcoholic fatty liver disease. Nutrients. 2017,9(9),981. http:\/\/dx.doi.org\/10.3390\/nu9090981 PMID: 28878197","journal-title":"Nutrients"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","volume":"48(6)","author":"Ouyang,X.","year":"2008","unstructured":"Ouyang,X.; Cirillo,P.; Sautin,Y.; McCall,S.; Bruchette, J.L.; Diehl, A.M.; Johnson, R.J.; Abdelmalek, M.F. Fruc-tose consumption as a risk factor for non-alcoholic fatty liver disease, J. Hepatol. 2008,48(6),993-999. http:\/\/dx.doi.org\/10.1016\/j.jhep.2008.02.011 PMID: 18395287","journal-title":"Hepatol"},{"key":"ref=34","author":"Siddiqui, R.A.","unstructured":"Siddiqui, R.A.; Xu,Z.; Harvey, K.A.; Pavlina, T.M.; Becker, M.J.; Zaloga, G.P. Comparative study of the modu-lation of fructose\/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content. Nutr. Metab. (Lond.),2015,12,41. http:\/\/dx.doi.org\/10.1186\/s12986-015-0038-x PMID: 26583036","journal-title":"Nutr.Metab.(Lond.),"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/md13041864","volume":"13(4)","author":"de Castro, G.S.","year":"2015","unstructured":"de Castro, G.S.; Deminice,R.; Sim\u00f5es-Ambrosio, L.M.; Calder, P.C.; Jord\u00e3o, A.A.; Vannucchi, H. Dietary docosa-hexaenoic acid and eicosapentaenoic acid influence liver triacylglycerol and insulin resistance in rats fed a high-fructose diet. Mar. Drugs. 2015,13(4),1864-1881. http:\/\/dx.doi.org\/10.3390\/md13041864 PMID: 25837985","journal-title":"Mar.Drugs"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.toxlet.2012.06.002","volume":"212(3)","author":"Zhang,C.","year":"2012","unstructured":"Zhang,C.; Chen,X.; Zhu, R.M.; Zhang,Y.; Yu,T.; Wang,H.; Zhao,H.; Zhao,M.; Ji, Y.L.; Chen, Y.H.; Meng, X.H.; Wei,W.; Xu, D.X. Endoplasmic reticulum stress is in-volved in hepatic SREBP-1c activation and lipid accumula-tion in fructose-fed mice. Toxicol. Lett. 2012,212(3),229-240. http:\/\/dx.doi.org\/10.1016\/j.toxlet.2012.06.002 PMID: 22698815","journal-title":"Toxicol.Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1089\/ars.2014.5868","volume":"22(10)","author":"Zhang,X.","year":"2015","unstructured":"Zhang,X.; Zhang, J.H.; Chen, X.Y.; Hu, Q.H.; Wang, M.X.; Jin,R.; Zhang, Q.Y.; Wang,W.; Wang,R.; Kang, L.L.; Li, J.S.; Li,M.; Pan,Y.; Huang, J.J.; Kong, L.D. Re-active oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid. Redox Signal. 2015,22(10),848-870. http:\/\/dx.doi.org\/10.1089\/ars.2014.5868 PMID: 25602171","journal-title":"Antioxid.Redox Signal"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jhep.2004.07.002","volume":"41(5)","author":"Piquet, M.A.","year":"2004","unstructured":"Piquet, M.A.; Roulet,M.; Nogueira,V.; Filippi,C.; Sibille,B.; Hourmand-Ollivier,I.; Pilet,M.; Rouleau,V.; Leverve, X.M. Polyunsaturated fatty acid deficiency reverses effects of alcohol on mitochondrial energy metabolism, J. Hepa-tol. 2004,41(5),721-729. http:\/\/dx.doi.org\/10.1016\/j.jhep.2004.07.002 PMID: 15519643","journal-title":"Hepa-tol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","volume":"136(5)","author":"Kirk,E.","year":"2009","unstructured":"Kirk,E.; Reeds, D.N.; Finck, B.N.; Mayurranjan, S.M.; Patterson, B.W.; Klein, S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restric-tion. Gastroenterology. 2009,136(5),1552-1560. http:\/\/dx.doi.org\/10.1053\/j.gastro.2009.01.048 PMID: 19208352","journal-title":"Gastroenterology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jnutbio.2012.03.004","volume":"23(9)","author":"Lottenberg, A.M.","year":"2012","unstructured":"Lottenberg, A.M.; Afonso, Mda.S.; Lavrador, M.S.; Machado, R.M.; Nakandakare, E.R. The role of dietary fatty acids in the pathology of metabolic syndrome, J. Nutr. Biochem. 2012,23(9),1027-1040. http:\/\/dx.doi.org\/10.1016\/j.jnutbio.2012.03.004 PMID: 22749135","journal-title":"Nutr.Biochem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.clnu.2006.01.027","volume":"25(5)","author":"Cortez-Pinto,H.","year":"2006","unstructured":"Cortez-Pinto,H.; Jesus,L.; Barros,H.; Lopes,C.; Moura, M.C.; Camilo, M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006,25(5),816-823. http:\/\/dx.doi.org\/10.1016\/j.clnu.2006.01.027 PMID: 16677739","journal-title":"Nutr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","volume":"86(2)","author":"Zivkovic, A.M.","year":"2007","unstructured":"Zivkovic, A.M.; German, J.B.; Sanyal, A.J. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am, J. Clin. Nutr. 2007,86(2),285-300. http:\/\/dx.doi.org\/10.1093\/ajcn\/86.2.285 PMID: 17684197","journal-title":"Am, J.Clin.Nutr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e91436.","DOI":"10.1371\/journal.pone.0091436","volume":"9(3)","author":"Yaligar,J.","year":"2014","unstructured":"Yaligar,J.; Gopalan,V.; Kiat, O.W.; Sugii,S.; Shui,G.; Lam, B.D.; Henry, C.J.; Wenk, M.R.; Tai, E.S.; Velan, S.S. Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS tech-niques. PLoS One. 2014,9(3),e91436. http:\/\/dx.doi.org\/10.1371\/journal.pone.0091436 PMID: 24638096","journal-title":"PLoS One"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.clnu.2010.06.001","volume":"30(1)","author":"Shapiro,H.","year":"2011","unstructured":"Shapiro,H.; Tehilla,M.; Attal-Singer,J.; Bruck,R.; Luz-zatti,R.; Singer, P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin. Nutr. 2011,30(1),6-19. http:\/\/dx.doi.org\/10.1016\/j.clnu.2010.06.001 PMID: 20619513","journal-title":"Clin.Nutr"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3945\/ajcn.110.006643","volume":"93(5)","author":"Blasbalg, T.L.","year":"2011","unstructured":"Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am, J. Clin. Nutr. 2011,93(5),950-962. http:\/\/dx.doi.org\/10.3945\/ajcn.110.006643 PMID: 21367944","journal-title":"Am, J.Clin.Nutr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"539426.","DOI":"10.1155\/2012\/539426","volume":"2012","author":"Patterson,E.","year":"2012","unstructured":"Patterson,E.; Wall,R.; Fitzgerald, G.F.; Ross, R.P.; Stanton, C. Health implications of high dietary omega-6 polyunsaturated fatty acids, J. Nutr. Metab. 2012,2012,539426. http:\/\/dx.doi.org\/10.1155\/2012\/539426 PMID: 22570770","journal-title":"Nutr.Metab"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e23365.","DOI":"10.1371\/journal.pone.0023365","volume":"6(8)","author":"Pachikian, B.D.","year":"2011","unstructured":"Pachikian, B.D.; Essaghir,A.; Demoulin, J.B.; Neyrinck, A.M.; Catry,E.; De Backer, F.C.; Dejeans,N.; Dewulf, E.M.; Sohet, F.M.; Portois,L.; Deldicque,L.; Molendi-Coste,O.; Leclercq, I.A.; Francaux,M.; Carpentier, Y.A.; Foufelle,F.; Muccioli, G.G.; Cani, P.D.; Delzenne, N.M. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS One. 2011,6(8),e23365. http:\/\/dx.doi.org\/10.1371\/journal.pone.0023365 PMID: 21853118","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/nu5082901","volume":"5(8)","author":"Simopoulos,A.P","year":"2013","unstructured":"Simopoulos.; A.P. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients. 2013,5(8),2901-2923. http:\/\/dx.doi.org\/10.3390\/nu5082901 PMID: 23896654","journal-title":"Nutrients"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ejcn.2010.35","volume":"64(6)","author":"Mager, D.R.","year":"2010","unstructured":"Mager, D.R.; Patterson,C.; So,S.; Rogenstein, C.D.; Wykes, L.J.; Roberts, E.A. Dietary and physical activity patterns in children with fatty liver. Eur, J. Clin. Nutr. 2010,64(6),628-635. http:\/\/dx.doi.org\/10.1038\/ejcn.2010.35 PMID: 20216561","journal-title":"Eur, J.Clin.Nutr"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/MPG.0b013e3182a1df77","volume":"57(5)","author":"St-Jules, D.E.","year":"2013","unstructured":"St-Jules, D.E.; Watters, C.A.; Brunt, E.M.; Wilkens, L.R.; Novotny,R.; Belt,P.; Lavine, J.E. Nonalcoholic steatohe-patitis clinical research network. Estimation of fish and ?-3 fatty acid intake in pediatric nonalcoholic fatty liver dis-ease, J. Pediatr. Gastroenterol. Nutr. 2013,57(5),627-633. http:\/\/dx.doi.org\/10.1097\/MPG.0b013e3182a1df77 PMID: 24177784","journal-title":"Estimation of fish and ?-3 fatty acid intake in pediatric nonalcoholic fatty liver dis-ease, J.Pediatr.Gastroenterol.Nutr"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3748\/wjg.v16.i7.800","volume":"16(7)","author":"Enjoji,M.","year":"2010","unstructured":"Enjoji,M.; Nakamuta, M. Is the control of dietary choles-terol intake sufficiently effective to ameliorate nonalco-holic fatty liver disease? World J. Gastroenterol. 2010,16(7),800-803. https:\/\/dx.doi.org\/10.3748\/wjg.v16.i7.800 PMID: 20143458","journal-title":"Gastroenterol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3748\/wjg.v20.i7.1746","volume":"20(7)","author":"Ferramosca,A.","year":"2014","unstructured":"Ferramosca,A.; Zara, V. Modulation of hepatic steatosis by dietary fatty acids. World J. Gastroenterol. 2014,20(7),1746-1755. http:\/\/dx.doi.org\/10.3748\/wjg.v20.i7.1746 PMID: 24587652","journal-title":"World J.Gastroenterol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1017\/S0007114508027451","volume":"101(5)","author":"Kelley, D.S.","year":"2009","unstructured":"Kelley, D.S.; Vemuri,M.; Adkins,Y.; Gill, S.H.; Fedor,D.; Mackey, B.E. Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br, J. Nutr. 2009,101(5),701-708. http:\/\/dx.doi.org\/10.1017\/S0007114508027451 PMID: 18710604","journal-title":"Br, J.Nutr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390 \/ijms18122645","volume":"18(12)","author":"Costantini,L.","year":"2017","unstructured":"Costantini,L.; Molinari,R.; Farinon,B.; Merendino, N. Impact of omega-3 fatty acids on the gut microbiota. Int, J. Mol. Sci. 2017,18(12),1-18. http:\/\/dx.doi.org\/10.3390 \/ijms18122645 PMID: 29215589","journal-title":"Int, J.Mol.Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.molmed.2006.10.001","volume":"12(12)","author":"Videla, L.A.","year":"2006","unstructured":"Videla, L.A.; Rodrigo,R.; Araya,J.; Poniachik, J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol. Med. 2006,12(12),555-558. http:\/\/dx.doi.org\/10.1016\/j.molmed.2006.10.001 PMID: 17049925","journal-title":"Trends Mol.Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50(8)","author":"Marchesini,G.","year":"2001","unstructured":"Marchesini,G.; Brizi,M.; Bianchi,G.; Tomassetti,S.; Bugianesi,E.; Lenzi,M.; McCullough, A.J.; Natale,S.; Forlani,G.; Melchionda, N. Nonalcoholic fatty liver dis-ease: a feature of the metabolic syndrome. Diabetes. 2001,50(8),1844-1850. http:\/\/dx.doi.org\/10.2337\/diabetes.50.8.1844 PMID: 11473047","journal-title":"Diabetes"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141(4)","author":"Charlton, M.R.","year":"2011","unstructured":"Charlton, M.R.; Burns, J.M.; Pedersen, R.A.; Watt, K.D.; Heimbach, J.K.; Dierkhising, R.A. Frequency and out-comes of liver transplantation for nonalcoholic steatohepa-titis in the United States. Gastroenterology. 2011,141(4),1249-1253. http:\/\/dx.doi.org\/10.1053\/j.gastro.2011.06.061 PMID: 21726509","journal-title":"Gastroenterology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1194\/jlr.R008896","volume":"52(4)","author":"Hooper, A.J.","year":"2011","unstructured":"Hooper, A.J.; Adams, L.A.; Burne-tt, J.R. Genetic determi-nants of hepatic steatosis in man, J. Lipid Res. 2011,52(4),593-617. http:\/\/dx.doi.org\/10.1194\/jlr.R008896 PMID: 21245030","journal-title":"Lipid Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2174\/138161210791208875","volume":"16(17)","author":"Bugianesi,E.","year":"2010","unstructured":"Bugianesi,E.; Moscatiello,S.; Ciaravella, M.F.; Marchesini, G. Insulin resistance in nonalcoholic fatty liver disease. Curr. Pharm. Des. 2010,16(17),1941-1951. http:\/\/dx.doi.org\/10.2174\/138161210791208875 PMID: 20370677","journal-title":"Curr.Pharm.Des"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1039\/c1fo10133a","volume":"2(11)","author":"Valenzuela,R.","year":"2011","unstructured":"Valenzuela,R.; Videla, L.A. The importance of the long-chain polyunsaturated fatty acid n-6\/n-3 ratio in develop-ment of non-alcoholic fatty liver associated with obesity. Food Funct. 2011,2(11),644-648. http:\/\/dx.doi.org\/10.1039\/c1fo10133a PMID: 22008843","journal-title":"Food Funct"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2015.09.004","volume":"89","author":"Videla, L.A.","year":"2015","unstructured":"Videla, L.A.; Fern\u00e1ndez,V.; Cornejo,P.; Vargas,R.; Car-rasco,J.; Fern\u00e1ndez,J.; Varela, N. Causal role of oxidative stress in unfolded protein response development in the hy-perthyroid state. Free Radic. Biol. Med. 2015,89,401-408. http:\/\/dx.doi.org\/10.1016\/j.freeradbiomed.2015.09.004 PMID: 26434419","journal-title":"Free Radic.Biol.Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"95974.","DOI":"10.1155\/2007\/95974","volume":"2007","author":"Stienstra,R.","year":"2007","unstructured":"Stienstra,R.; Duval,C.; M\u00fcller,M.; Kersten, S. PPARs, obesity and inflammation. PPAR Res. 2007,2007,95974. http:\/\/dx.doi.org\/10.1155\/2007\/95974 PMID: 17389767","journal-title":"PPAR Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","volume":"26(5)","author":"Berger, J.P.","year":"2005","unstructured":"Berger, J.P.; Akiyama, T.E.; Meinke, P.T. PPARs: thera-peutic targets for metabolic disease. Trends Pharmacol. Sci. 2005,26(5),244-251. http:\/\/dx.doi.org\/10.1016\/j.tips.2005.03.003 PMID: 15860371","journal-title":"Trends Pharmacol.Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4254\/wjh.v7.i8.1012","volume":"7(8)","author":"Souza-Mello.","year":"2015","unstructured":"Souza-Mello.; V. Peroxisome proliferator-activated recep-tors as targets to treat non-alcoholic fatty liver disease. World J. Hepatol. 2015,7(8),1012-1019. http:\/\/dx.doi.org\/10.4254\/wjh.v7.i8.1012 PMID: 26052390","journal-title":"World J.Hepatol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0028502","volume":"6","author":"Z\u00fa\u00f1iga,J.","year":"2011","unstructured":"Z\u00fa\u00f1iga,J.; Cancino,M.; Medina,F.; Varela,P.; Vargas,R.; Tapia, G. N-3 PUFA supplementation triggers PPAR-a ac-tivation and PPAR-a\/NF-?B interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One. 2011,6,1-10. http:\/\/dx.doi.org\/10.1371\/journal.pone.0028502 PMID: 22174823","journal-title":"PLoS One"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1161\/01.CIR.99.24.3125","volume":"99(24)","author":"Marx,N.","year":"1999","unstructured":"Marx,N.; Sukhova, G.K.; Collins,T.; Libby,P.; Plutzky, J. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 1999,99(24),3125-3131. http:\/\/dx.doi.org\/10.1161\/01.CIR.99.24.3125 PMID: 10377075","journal-title":"Circulation"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","volume":"72(11)","author":"Gloire,G.","year":"2006","unstructured":"Gloire,G.; Legrand-Poels,S.; Piette, J. NF-kappaB activa-tion by reactive oxygen species: fifteen years later. Bio-chem. Pharmacol. 2006,72(11),1493-1505. http:\/\/dx.doi.org\/10.1016\/j.bcp.2006.04.011 PMID: 16723122","journal-title":"Bio-chem.Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/oby.2008.601","volume":"17(5)","author":"Videla, L.A.","year":"2009","unstructured":"Videla, L.A.; Tapia,G.; Rodrigo,R.; Pettinelli,P.; Haim,D.; Santiba\u00f1ez,C.; Araya, A.V.; Smok,G.; Csendes,A.; Gutierrez,L.; Rojas,J.; Castillo,J.; Korn,O.; Maluenda,F.; D\u00edaz, J.C.; Rencoret,G.; Poniachik, J. Liver NF-kappaB and AP-1 DNA binding in obese patients. Obesity (Silver Spring). 2009,17(5),973-979. http:\/\/dx.doi.org\/10.1038\/oby.2008.601 PMID: 19165171","journal-title":"Obesity (Silver Spring)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbadis.2009.08.015","volume":"1792(11)","author":"Pettinelli,P.","year":"2009","unstructured":"Pettinelli,P.; Del Pozo,T.; Araya,J.; Rodrigo,R.; Araya, A.V.; Smok,G.; Csendes,A.; Gutierrez,L.; Rojas,J.; Korn,O.; Maluenda,F.; Diaz, J.C.; Rencoret,G.; Braghetto,I.; Castillo,J.; Poniachik,J.; Videla, L.A. En-hancement in liver SREBP-1c\/PPAR-alpha ratio and stea-tosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim. Biophys. Acta. 2009,1792(11),1080-1086. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2009.08.015 PMID: 19733654","journal-title":"Biochim.Biophys.Acta"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.clnu.2010.03.006","volume":"29(5)","author":"Videla,L.A","year":"2010","unstructured":"Videla.; L.A. Liver NF-?B and AP-1 activation and PPAR-a expression are negatively correlated in obese patients: pro-inflammatory implications. Clin. Nutr. 2010,29(5),687-688. http:\/\/dx.doi.org\/10.1016\/j.clnu.2010.03.006 PMID: 20403650","journal-title":"Clin.Nutr"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","volume":"1821(5)","author":"Tailleux,A.","year":"2012","unstructured":"Tailleux,A.; Wouters,K.; Staels, B. Roles of PPARs in NAFLD: potential therapeutic targets. Biochim. Biophys. Acta. 2012,1821(5),809-818. http:\/\/dx.doi.org\/10.1016\/j.bbalip.2011.10.016 PMID: 22056763","journal-title":"Biochim.Biophys.Acta"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34(6)","author":"Suzuki,T.","year":"2013","unstructured":"Suzuki,T.; Motohashi,H.; Yamamoto, M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 2013,34(6),340-346. http:\/\/dx.doi.org\/10.1016\/j.tips.2013.04.005 PMID: 23664668","journal-title":"Trends Pharmacol.Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1074\/jbc.M607622200","volume":"282(4)","author":"Gao,L.","year":"2007","unstructured":"Gao,L.; Wang,J.; Sekhar, K.R.; Yin,H.; Yared, N.F.; Schneider, S.N.; Sasi,S.; Dalton, T.P.; Anderson, M.E.; Chan, J.Y.; Morrow, J.D.; Freeman, M.L. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J. Biol. Chem. 2007,282(4),2529-2537. http:\/\/dx.doi.org\/10.1074\/jbc.M607622200 PMID: 17127771","journal-title":"J.Biol.Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/BF02535573","volume":"27(12)","author":"Demoz,A.","year":"1992","unstructured":"Demoz,A.; Willumsen,N.; Berge, R.K. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic anti-oxidant defense in mice. Lipids. 1992,27(12),968-971. http:\/\/dx.doi.org\/10.1007\/BF02535573 PMID: 1487958","journal-title":"Lipids"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","volume":"298(2)","author":"Sugimoto,H.","year":"2010","unstructured":"Sugimoto,H.; Okada,K.; Shoda,J.; Warabi,E.; Ishige,K.; Ueda,T.; Taguchi,K.; Yanagawa,T.; Nakahara,A.; Hyodo,I.; Ishii,T.; Yamamoto, M. Deletion of nuclear fac-tor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am, J. Physiol. Gas-trointest. Liver Physiol. 2010,298(2),G283-G294. http:\/\/dx.doi.org\/10.1152\/ajpgi.00296.2009 PMID: 19926817","journal-title":"Am, J.Physiol.Gas-trointest.Liver Physiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1089\/ars.2010.3216","volume":"13(11)","author":"Wakabayashi,N.","year":"2010","unstructured":"Wakabayashi,N.; Slocum, S.L.; Skoko, J.J.; Shin,S.; Ken-sler, T.W. When NRF2 talks, who\u2019s listening? Antioxid. Redox Signal. 2010,13(11),1649-1663. http:\/\/dx.doi.org\/10.1089\/ars.2010.3216 PMID: 20367496","journal-title":"Redox Signal"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.4049 \/jimmunol.179.11.7840","volume":"179(11)","author":"Seldon, M.P.","year":"2007","unstructured":"Seldon, M.P.; Silva,G.; Pejanovic,N.; Larsen,R.; Gre-goire, I.P.; Filipe,J.; Anrather,J.; Soares, M.P. Heme oxy-genase-1 inhibits the expression of adhesion molecules as-sociated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J. Immu-nol. 2007,179(11),7840-7851. http:\/\/dx.doi.org\/10.4049 \/jimmunol.179.11.7840 PMID: 18025230","journal-title":"J.Immu-nol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jnutbio.2015.02.001","volume":"26(6)","author":"Bhaswant,M.","year":"2015","unstructured":"Bhaswant,M.; Poudyal,H.; Brown, L. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsatu-rated fatty acids, J. Nutr. Biochem. 2015,26(6),571-584. http:\/\/dx.doi.org\/10.1016\/j.jnutbio.2015.02.001 PMID: 25841249","journal-title":"Nutr.Biochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.amjcard.2016.10.027","volume":"119(3)","author":"Mosca,L.","year":"2017","unstructured":"Mosca,L.; Ballantyne, C.M.; Bays, H.E.; Guyton, J.R.; Philip,S.; Doyle, R.T. Jr; Juliano, R.A. Usefulness of icosapent ethyl (eicosapentaenoic acid ethyl ester)  in women to lower triglyceride levels (Results from the MA-RINE and ANCHOR trials) . Am, J. Cardiol. 2017,119(3),397-403. http:\/\/dx.doi.org\/10.1016\/j.amjcard.2016.10.027 PMID: 27939227","journal-title":".Am, J.Cardiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2017.08.001","volume":"124","author":"Echeverr\u00eda,F.","year":"2017","unstructured":"Echeverr\u00eda,F.; Valenzuela,R.; Catalina Hernandez-Rodas,M.; Valenzuela, A. Docosahexaenoic acid (DHA),a fun-damental fatty acid for the brain: new dietary sources. Prostaglandins Leukot. Essent. Fatty Acids. 2017,124,1-10. http:\/\/dx.doi.org\/10.1016\/j.plefa.2017.08.001 PMID: 28870371","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/mnfr.201300458","volume":"58(6)","author":"Tapia,G.","year":"2014","unstructured":"Tapia,G.; Valenzuela,R.; Espinosa,A.; Romanque,P.; Dossi,C.; Gonzalez-Ma\u00f1\u00e1n,D.; Videla, L.A.; D\u2019Espessailles, A. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and in-flammation in relation to PPAR-a upregulation and NF-?B DNA binding abrogation. Mol. Nutr. Food Res. 2014,58(6),1333-1341. http:\/\/dx.doi.org\/10.1002\/mnfr.201300458 PMID: 24436018","journal-title":"Mol.Nutr.Food Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1700470.","DOI":"10.1002\/mnfr.201700479","volume":"61(12)","author":"Hern\u00e1ndez-Rodas, M.C.","year":"2017","unstructured":"Hern\u00e1ndez-Rodas, M.C.; Valenzuela,R.; Echeverr\u00eda,F.; Rinc\u00f3n-Cervera, M.A.; Espinosa,A.; Illesca,P.; Mu\u00f1oz,P.; Corbari,A.; Romero,N.; Gonzalez-Ma\u00f1an,D.; Videla, L.A. Supplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR-a and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation. Mol. Nutr. Food Res. 2017,61(12),1700470. http:\/\/dx.doi.org\/10.1002\/mnfr.201700479 PMID: 28940752","journal-title":"Mol.Nutr.Food Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.bbalip.2015.08.007","volume":"1851(12)","author":"Deng,X.","year":"2015","unstructured":"Deng,X.; Dong,Q.; Bridges,D.; Raghow,R.; Park, E.A.; Elam, M.B. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c)  via activation of AMP-activated kinase. Bio-chim. Biophys. Acta. 2015,1851(12),1521-1529. http:\/\/dx.doi.org\/10.1016\/j.bbalip.2015.08.007 PMID: 26327595","journal-title":"Bio-chim.Biophys.Acta"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1258\/ebm.2010.009298","volume":"235(7)","author":"Simopoulos,A.P","year":"2010","unstructured":"Simopoulos.; A.P. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determi-nation of nutritional requirements and chronic disease risk. Exp. Biol. Med. (Maywood). 2010,235(7),785-795. http:\/\/dx.doi.org\/10.1258\/ebm.2010.009298 PMID: 20558833","journal-title":"Exp.Biol.Med.(Maywood)"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/advances\/nmy007","volume":"9(3)","author":"Sullivan, E.M.","year":"2018","unstructured":"Sullivan, E.M.; Pennington, E.R.; Green, W.D.; Beck, M.A.; Brown, D.A.; Shaikh, S.R. Mechanisms by which dietary fatty acids regulate mitochondrial structure-function in health and disease. Adv. Nutr. 2018,9(3),247-262. http:\/\/dx.doi.org\/10.1093\/advances\/nmy007 PMID: 29767698","journal-title":"Adv.Nutr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1152\/ajpendo.00644.2005","volume":"291(2)","author":"Wei,Y.","year":"2006","unstructured":"Wei,Y.; Wang,D.; Topczewski,F.; Pagliassotti, M.J. Satu-rated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am, J. Physiol. Endocrinol. Metab. 2006,291(2),E275-E281. http:\/\/dx.doi.org\/10.1152\/ajpendo.00644.2005 PMID: 16492686","journal-title":"Am, J.Physiol.Endocrinol.Metab"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4254\/wjh.v2.i6.203","volume":"2(6)","author":"Zheng,Z.","year":"2010","unstructured":"Zheng,Z.; Zhang,C.; Zhang, K. Role of unfolded protein response in lipogenesis. World J. Hepatol. 2010,2(6),203-207. http:\/\/dx.doi.org\/10.4254\/wjh.v2.i6.203 PMID: 21160998","journal-title":"World J.Hepatol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","volume":"52(1)","author":"Leamy, A.K.","year":"2013","unstructured":"Leamy, A.K.; Egnatchik, R.A.; Young, J.D. Molecular mechanisms and the role of saturated fatty acids in the pro-gression of non-alcoholic fatty liver disease. Prog. Lipid Res. 2013,52(1),165-174. http:\/\/dx.doi.org\/10.1016\/j.plipres.2012.10.004 PMID: 23178552","journal-title":"Prog.Lipid Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"122.","DOI":"10.1186\/1476-511X-10-122","volume":"10","author":"Zhang,Y.","year":"2011","unstructured":"Zhang,Y.; Yang,X.; Shi,H.; Dong,L.; Bai, J. Effect of a-linolenic acid on endoplasmic reticulum stress-mediated apoptosis of palmitic acid lipotoxicity in primary rat hepa-tocytes. Lipids Health Dis. 2011,10,122. http:\/\/dx.doi.org\/10.1186\/1476-511X-10-122 PMID: 21787405","journal-title":"Lipids Health Dis"},{"key":"ref=90","author":"Videla, L.A.","unstructured":"Videla, L.A.; Rodrigo,R.; Orellana,M.; Fern\u00e1ndez,V.; Tapia,G.; Qui\u00f1ones,L.; Varela,N.; Contreras,J.; Lazarte,R.; Csendes,A.; Rojas,J.; Maluenda,F.; Burdiles,P.; Diaz, J.C.; Smok,G.; Thielemann,L.; Poniachik, J. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond.),2004,106(3),261-268. http:\/\/dx.doi.org\/10.1042\/CS20030285 PMID: 14556645","journal-title":"Clin.Sci.(Lond.)"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1074\/jbc.M411860200","volume":"280(1)","author":"Nakatani,Y.","year":"2005","unstructured":"Nakatani,Y.; Kaneto,H.; Kawamori,D.; Yoshiuchi,K.; Hatazaki,M.; Matsuoka, T.A.; Ozawa,K.; Ogawa,S.; Hori,M.; Yamasaki,Y.; Matsuhisa, M. Involvement of en-doplasmic reticulum stress in insulin resistance and diabe-tes, J. Biol. Chem. 2005,280(1),847-851. http:\/\/dx.doi.org\/10.1074\/jbc.M411860200 PMID: 15509553","journal-title":"Biol.Chem"},{"key":"ref=92","author":"Song,J.","unstructured":"Song,J.; Li,C.; Lv,Y.; Zhang,Y.; Amakye, W.K.; Mao, L. DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPAR? and its phosphorylation at Ser273 in 3T3-L1 adipo-cytes. Nutr. Metab. (Lond.),2017,14,52. http:\/\/dx.doi.org\/10.1186\/s12986-017-0209-z PMID: 28811832","journal-title":"Nutr.Metab.(Lond.)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jhep.2010.07.039","volume":"54(3)","author":"Miyoshi,H.","year":"2011","unstructured":"Miyoshi,H.; Moriya,K.; Tsutsumi,T.; Shinzawa,S.; Fujie,H.; Shintani,Y.; Fujinaga,H.; Goto,K.; Todoroki,T.; Su-zuki,T.; Miyamura,T.; Matsuura,Y.; Yotsuyanagi,H.; Koike, K. Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid al-terations induced by the core protein, J. Hepatol. 2011,54(3),432-438. http:\/\/dx.doi.org\/10.1016\/j.jhep.2010.07.039 PMID: 21093950","journal-title":"Hepatol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1203\/01.PDR.0000153672.43030.75","volume":"57(3)","author":"Alwayn, I.P.","year":"2005","unstructured":"Alwayn, I.P.; Gura,K.; Nos\u00e9, V.; Zausche,B.; Javid,P.; Garza,J.; Verbesey,J.; Voss,S.; Ollero,M.; Andersson,C.; Bistrian,B.; Folkman,J.; Puder, M. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr. Res. 2005,57(3),445-452. http:\/\/dx.doi.org\/10.1203\/01.PDR.0000153672.43030.75 PMID: 15659701","journal-title":"Pediatr.Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.08-125674","volume":"23(6)","author":"Gonz\u00e1lez-P\u00e9riz,A.","year":"2009","unstructured":"Gonz\u00e1lez-P\u00e9riz,A.; Horrillo,R.; Ferr\u00e9, N.; Gronert,K.; Dong,B.; Mor\u00e1n-Salvador,E.; Titos,E.; Mart\u00ednez-Clemente,M.; L\u00f3pez-Parra,M.; Arroyo,V.; Cl\u00e0ria, J. Obe-sity-induced insulin resistance and hepatic steatosis are al-leviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009,23(6),1946-1957. http:\/\/dx.doi.org\/10.1096\/fj.08-125674 PMID: 19211925","journal-title":"FASEB J"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jhep.2008.10.031","volume":"50(3)","author":"Ishii,H.","year":"2009","unstructured":"Ishii,H.; Horie,Y.; Ohshima,S.; Anezaki,Y.; Kinoshita,N.; Dohmen,T.; Kataoka,E.; Sato,W.; Goto,T.; Sasaki,J.; Sasaki,T.; Watanabe,S.; Suzuki,A.; Ohnishi, H. Eicosap-entaenoic acid ameliorates steatohepatitis and hepatocellu-lar carcinoma in hepatocyte-specific Pten-deficient mice, J. Hepatol. 2009,50(3),562-571. http:\/\/dx.doi.org\/10.1016\/j.jhep.2008.10.031 PMID: 19162361","journal-title":"Hepatol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2353\/ajpath.2006.050953","volume":"169(3)","author":"Svegliati-Baroni,G.","year":"2006","unstructured":"Svegliati-Baroni,G.; Candelaresi,C.; Saccomanno,S.; Ferretti,G.; Bachetti,T.; Marzioni,M.; De Minicis,S.; Nobili,L.; Salzano,R.; Omenetti,A.; Pacetti,D.; Sigmund,S.; Benedetti,A.; Casini, A. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsatu-rated fatty acid treatment on liver injury. Am, J. Pathol. 2006,169(3),846-860. http:\/\/dx.doi.org\/10.2353\/ajpath.2006.050953 PMID: 16936261","journal-title":"Am, J.Pathol"},{"key":"ref=98","first-page":"785","volume":"54(3) (Suppl. .)","author":"Popescu, L.A.","year":"2013","unstructured":"Popescu, L.A.; V\u00eergolici,B.; Lixandru,D.; Miricescu,D.; Condrut,E.; Timnea,O.; Ranetti, A.E.; Militaru,M.; Mo-hora,M.; Zagrean, L. Effect of diet and omega-3 fatty acids in NAFLD. Rom, J. Morphol. Embryol. 2013,54(3) (Suppl.),785-790. PMID: 24322028","journal-title":"Rom, J.Morphol.Embryol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11745-014-3892-9","volume":"49(5)","author":"Bargut, T.C.","year":"2014","unstructured":"Bargut, T.C.; Frantz, E.D.; Mandarim-de-Lacerda, C.A.; Aguila, M.B. Effects of a diet rich in n-3 polyunsaturated fatty acids on hepatic lipogenesis and beta-oxidation in mice. Lipids. 2014,49(5),431-444. http:\/\/dx.doi.org\/10.1007\/s11745-014-3892-9 PMID: 24627299","journal-title":"Lipids"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1440-1746.2007.05157.x","volume":"23(2)","author":"Larter, C.Z.","year":"2008","unstructured":"Larter, C.Z.; Yeh, M.M.; Cheng,J.; Williams,J.; Brown,S.; dela Pena,A.; Bell-Anderson, K.S.; Farrell, G.C. Acti-vation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperox-ide accumulation, J. Gastroenterol. Hepatol. 2008,23(2),267-275. http:\/\/dx.doi.org\/10.1111\/j.1440-1746.2007.05157.x PMID: 17868330","journal-title":"Gastroenterol.Hepatol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jnutbio.2014.04.011","volume":"25(9)","author":"Dossi, C.G.","year":"2014","unstructured":"Dossi, C.G.; Tapia, G.S.; Espinosa,A.; Videla, L.A.; D\u2019Espessailles, A. Reversal of high-fat diet-induced he-patic steatosis by n-3 LCPUFA: role of PPAR-a and SREBP-1c, J. Nutr. Biochem. 2014,25(9),977-984. http:\/\/dx.doi.org\/10.1016\/j.jnutbio.2014.04.011 PMID: 24993917","journal-title":"Nutr.Biochem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3892 \/ijmm.18.6.1047","volume":"18(6)","author":"Louchami,K.","year":"2006","unstructured":"Louchami,K.; Zhang,Y.; Oguzhan,B.; Delporte,C.; Por-tois,L.; Carpentier, Y.A.; Genten,F.; Danguy,A.; Mal-aisse, W.J.; Sener, A. Rapid changes in liver lipid composi-tion and pancreatic islet K + handling and secretory behav-iour provoked by the intravenous administration of a me-dium-chain triglyceride: fish oil emulsion to long-chain polyunsaturated omega3 fatty acid-depleted rats. Int, J. Mol. Med. 2006,18(6),1047-1055. http:\/\/dx.doi.org\/10.3892 \/ijmm.18.6.1047 PMID: 17089007","journal-title":"Int, J.Mol.Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"21.","DOI":"10.1186\/1472-6793-8-21","volume":"8","author":"Pachikian, B.D.","year":"2008","unstructured":"Pachikian, B.D.; Neyrinck, A.M.; Cani, P.D.; Portois,L.; Deldicque,L.; De Backer, F.C.; Bindels, L.B.; Sohet, F.M.; Malaisse, W.J.; Francaux,M.; Carpentier, Y.A.; Delzenne, N.M. Hepatic steatosis in n-3 fatty acid depleted mice: fo-cus on metabolic alterations related to tissue fatty acid composition. BMC Physiol. 2008,8,21. http:\/\/dx.doi.org\/10.1186\/1472-6793-8-21 PMID: 19046413","journal-title":"BMC Physiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"504.","DOI":"10.1038\/427504a","volume":"427(6974)","author":"Kang, J.X.","year":"2004","unstructured":"Kang, J.X.; Wang,J.; Wu,L.; Kang, Z.B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature. 2004,427(6974),504. http:\/\/dx.doi.org\/10.1038\/427504a PMID: 14765186","journal-title":"Nature"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bcp.2012.08.029","volume":"84(10)","author":"Kim, E.H.","year":"2012","unstructured":"Kim, E.H.; Bae, J.S.; Hahm, K.B.; Cha, J.Y. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. Biochem. Pharmacol. 2012,84(10),1359-1365. http:\/\/dx.doi.org\/10.1016\/j.bcp.2012.08.029 PMID: 22981383","journal-title":"Biochem.Pharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e83756.","DOI":"10.1371\/journal.pone.0083756","volume":"8(12)","author":"Depner, C.M.","year":"2013","unstructured":"Depner, C.M.; Traber, M.G.; Bobe,G.; Kensicki,E.; Bo-hren, K.M.; Milne,G.; Jump, D.B. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-\/-mice. PLoS One. 2013,8(12),e83756. http:\/\/dx.doi.org\/10.1371\/journal.pone.0083756 PMID: 24358308","journal-title":"PLoS One"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1073\/pnas.1422590112","volume":"112(2)","author":"L\u00f3pez-Vicario,C.","year":"2015","unstructured":"L\u00f3pez-Vicario,C.; Alcaraz-Quiles,J.; Garc\u00eda-Alonso,V.; Rius,B.; Hwang, S.H.; Titos,E.; Lopategi,A.; Hammock, B.D.; Arroyo,V.; Cl\u00e0ria, J. Inhib ition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides. Proc. Natl. Acad. Sci. USA. 2015,112(2),536-541. http:\/\/dx.doi.org\/10.1073\/pnas.1422590112 PMID: 25550510","journal-title":"Proc.Natl.Acad.Sci.USA"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1111\/bph.13844","volume":"174(14)","author":"Wang,C.","year":"2017","unstructured":"Wang,C.; Liu,W.; Yao,L.; Zhang,X.; Zhang,X.; Ye,C.; Jiang,H.; He,J.; Zhu,Y.; Ai, D. Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early oc-currence of nonalcoholic fatty liver disease. Br, J. Pharma-col. 2017,174(14),2358-2372. http:\/\/dx.doi.org\/10.1111\/bph.13844 PMID: 28471490","journal-title":"Br, J.Pharma-col"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.plefa.2013.09.009","volume":"89(6)","author":"Hanke,D.","year":"2013","unstructured":"Hanke,D.; Zahradka,P.; Mohankumar, S.K.; Clark, J.L.; Taylor, C.G. A diet high in a-linolenic acid and monoun-saturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats. Prostaglandins Leukot. Essent. Fatty Acids. 2013,89(6),391-401. http:\/\/dx.doi.org\/10.1016\/j.plefa.2013.09.009 PMID: 24140006","journal-title":"Prostaglandins Leukot.Essent.Fatty Acids"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1039\/C3FO60688K","volume":"5(7)","author":"Valenzuela,B.","year":"2014","unstructured":"Valenzuela B, R.; Barrera R, C.; Gonz\u00e1lez-Astorga,M.; Sanhueza C, J.; Valenzuela B, A. Alpha linolenic acid (ALA)  from Rosa canina, sacha inchi and chia oils may in-crease ALA accretion and its conversion into n-3 LCPUFA in diverse tissues of the rat. Food Funct. 2014,5(7),1564-1572. http:\/\/dx.doi.org\/10.1039\/C3FO60688K PMID: 24855655","journal-title":"Food Funct"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3945\/jn.116.243261","volume":"147(4)","author":"Gonz\u00e1lez-Ma\u00f1\u00e1n,D.","year":"2017","unstructured":"Gonz\u00e1lez-Ma\u00f1\u00e1n,D.; D\u2019Espessailles,A.; Dossi, C.G.; San Mart\u00edn,M.; Mancilla, R.A.; Tapia, G.S. Rosa mosqueta oil prevents oxidative stress and inflammation through the upregulation of PPAR-a and NRF2 in C57BL\/6J Mice fed a high-fat diet, J. Nutr. 2017,147(4),579-588. http:\/\/dx.doi.org\/10.3945\/jn.116.243261 PMID: 28298541","journal-title":"Nutr"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1039\/C6FO01762B","volume":"8(2)","author":"Dossi, C.G.","year":"2017","unstructured":"Dossi, C.G.; Cadagan,C.; San Mart\u00edn,M.; Espinosa,A.; Gonz\u00e1lez-Ma\u00f1\u00e1n,D.; Silva,D.; Mancilla, R.A.; Tapia, G.S. Effects of Rosa mosqueta oil supplementation in lipogenic markers associated with prevention of liver steatosis. Food Funct. 2017,8(2),832-841. http:\/\/dx.doi.org\/10.1039\/C6FO01762B PMID: 28128380","journal-title":"Food Funct"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1039\/C5FO00741K","volume":"6(9)","author":"D \u0099Espessailles,A.","year":"2015","unstructured":"D\u2019Espessailles,A.; Dossi, C.G.; Espinosa,A.; Gonz\u00e1lez-Ma\u00f1\u00e1n,D.; Tapia, G.S. Dietary Rosa mosqueta(Rosa ru-biginosa)  oil prevents high diet-induced hepatic steatosis in mice. Food Funct. 2015,6(9),3109-3116. http:\/\/dx.doi.org\/10.1039\/C5FO00741K PMID: 26218006","journal-title":"Food Funct"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1139\/cjpp-2012-0308","volume":"91(6)","author":"Monteiro,J.","year":"2013","unstructured":"Monteiro,J.; Askarian,F.; Nakamura, M.T.; Moghadasian, M.H.; Ma, D.W. Oils rich in a-linolenic acid independently protect against characteristics of fatty liver disease in the ?6-desaturase null mouse. Can, J. Physiol. Pharmacol. 2013,91(6),469-479. http:\/\/dx.doi.org\/10.1139\/cjpp-2012-0308 PMID: 23746194","journal-title":"Can, J.Physiol.Pharmacol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bbalip.2009.01.014","volume":"1791(4)","author":"Kajikawa,S.","year":"2009","unstructured":"Kajikawa,S.; Harada,T.; Kawashima,A.; Imada,K.; Mi-zuguchi, K. Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progres-sion of D-galactosamine-induced hepatitis in mice fed with a high-fat\/high-fructose diet. Biochim. Biophys. Acta. 2009,1791(4),281-288. https:\/\/dx.doi.org\/10.1016\/j.bbalip.2009.01.014 PMID: 19416647","journal-title":"Biochim.Biophys.Acta"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e0121528.","DOI":"10.1371\/journal.pone.0121528","volume":"10(3)","author":"Konuma,K.","year":"2015","unstructured":"Konuma,K.; Itoh,M.; Suganami,T.; Kanai,S.; Nakagawa,N.; Sakai,T.; Kawano,H.; Hara,M.; Kojima,S.; Izumi,Y.; Ogawa, Y. Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice. PLoS One. 2015,10(3),e0121528. http:\/\/dx.doi.org\/10.1371\/journal.pone.0121528 PMID: 25816330","journal-title":"PLoS One"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"30029.","DOI":"10.1038\/srep30029","volume":"6","author":"Zhang,K.","year":"2016","unstructured":"Zhang,K.; Chang,Y.; Shi,Z.; Han,X.; Han,Y.; Yao,Q.; Hu,Z.; Cui,H.; Zheng,L.; Han,T.; Hong, W. ?-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP\/TAZ deg-radation. Sci. Rep. 2016,6,30029. http:\/\/dx.doi.org\/10.1038\/srep30029 PMID: 27435808","journal-title":"Sci.Rep"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejbas.2014.12.005","volume":"2","author":"Abo,El-Magd.","year":"2015","unstructured":"Abo El-Magd, N.F.; El-Karef,A.; El-Shishtawy, M.M.; Eissa, L.A. Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on nuclear factor-kappa B pathway in thioacetamide-induced fibrosis in rats. Egyptian J. Basic Appl. Sci. 2015,2,65-74. http:\/\/dx.doi.org\/10.1016\/j.ejbas.2014.12.005","journal-title":"Egyptian J.Basic Appl.Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1590\/abd1806-4841.20176198","volume":"92(2)","author":"Torii,K.","year":"2017","unstructured":"Torii,K.; Maeshige,N.; Aoyama-Ishikawa,M.; Miyoshi,M.; Terashi,H.; Usami, M. Combination therapy with bu-tyrate and docosahexaenoic acid for keloid fibrogenesis: an in vitro study. An. Bras. Dermatol. 2017,92(2),184-190. http:\/\/dx.doi.org\/10.1590\/abd1806-4841.20176198 PMID: 28538876","journal-title":"An.Bras.Dermatol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.toxlet.2013.05.644","volume":"222(2)","author":"Li,Y.","year":"2013","unstructured":"Li,Y.; Liu,L.; Wang,B.; Xiong,J.; Li,Q.; Wang,J.; Chen, D. Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation. Toxicol. Lett. 2013,222(2),224-232. http:\/\/dx.doi.org\/10.1016\/j.toxlet.2013.05.644 PMID: 23747427","journal-title":"Toxicol.Lett"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142(5)","author":"Oh, D.Y.","year":"2010","unstructured":"Oh, D.Y.; Talukdar,S.; Bae, E.J.; Imamura,T.; Morinaga,H.; Fan,W.; Li,P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010,142(5),687-698. http:\/\/dx.doi.org\/10.1016\/j.cell.2010.07.041 PMID: 20813258","journal-title":"Cell"},{"key":"ref=122","author":"Byrne, C.D.","unstructured":"Byrne, C.D.; Olufadi,R.; Bruce, K.D.; Cagampang, F.R.; Ahmed, M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin. Sci. (Lond.),2009,116(7),539-564. http:\/\/dx.doi.org\/10.1042\/CS20080253 PMID: 19243311","journal-title":"Clin.Sci.(Lond.)"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","volume":"23(8)","author":"Capanni,M.","year":"2006","unstructured":"Capanni,M.; Calella,F.; Biagini, M.R.; Genise,S.; Rai-mondi,L.; Bedogni,G.; Svegliati-Baroni,G.; Sofi,F.; Mi-lani,S.; Abbate,R.; Surrenti,C.; Casini, A. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates he-patic steatosis in patients with non-alcoholic fatty liver dis-ease: a pilot study. Aliment. Pharmacol. Ther. 2006,23(8),1143-1151. http:\/\/dx.doi.org\/10.1111\/j.1365-2036.2006.02885.x PMID: 16611275","journal-title":"Aliment.Pharmacol.Ther"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3748\/wjg.14.6395","volume":"14(41)","author":"Zhu, F.S.","year":"2008","unstructured":"Zhu, F.S.; Liu,S.; Chen, X.M.; Huang, Z.G.; Zhang, D.W. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipi-demia. World J. Gastroenterol. 2008,14(41),6395-6400. http:\/\/dx.doi.org\/10.3748\/wjg.14.6395 PMID: 19009658","journal-title":"World J.Gastroenterol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","volume":"40(3)","author":"Spadaro,L.","year":"2008","unstructured":"Spadaro,L.; Magliocco,O.; Spampinato,D.; Piro,S.; Oliv-eri,C.; Alagona,C.; Papa,G.; Rabuazzo, A.M.; Purrello, F. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig. Liver Dis. 2008,40(3),194-199. http:\/\/dx.doi.org\/10.1016\/j.dld.2007.10.003 PMID: 18054848","journal-title":"Dig.Liver Dis"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3109\/09637486.2010.487480","volume":"61(8)","author":"Sofi,F.","year":"2010","unstructured":"Sofi,F.; Giangrandi,I.; Cesari,F.; Corsani,I.; Abbate,R.; Gensini, G.F.; Casini, A. Effects of a 1-year dietary inter-vention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a prelimi-nary study. Int, J. Food Sci. Nutr. 2010,61(8),792-802. http:\/\/dx.doi.org\/10.3109\/09637486.2010.487480 PMID: 20465434","journal-title":"Int, J.Food Sci.Nutr"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ejcn.2010.139","volume":"64(10)","author":"Oya,J.","year":"2010","unstructured":"Oya,J.; Nakagami,T.; Sasaki,S.; Jimba,S.; Murakami,K.; Kasahara,T.; Wasada,T.; Sekiguchi,H.; Hasegawa,M.; Endo,Y.; Iwamoto, Y. Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. Eur, J. Clin. Nutr. 2010,64(10),1179-1185. http:\/\/dx.doi.org\/10.1038\/ejcn.2010.139 PMID: 20683463","journal-title":"Eur, J.Clin.Nutr"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","volume":"42(4)","author":"Tanaka,N.","year":"2008","unstructured":"Tanaka,N.; Sano,K.; Horiuchi,A.; Tanaka,E.; Kiyosawa,K.; Aoyama, T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis, J. Clin. Gastroenterol. 2008,42(4),413-418. http:\/\/dx.doi.org\/10.1097\/MCG.0b013e31815591aa PMID: 18277895","journal-title":"Clin.Gastroenterol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","volume":"56(4)","author":"Parker, H.M.","year":"2012","unstructured":"Parker, H.M.; Johnson, N.A.; Burdon, C.A.; Cohn, J.S.; O\u2019Connor, H.T.; George, J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis, J. Hepatol. 2012,56(4),944-951. http:\/\/dx.doi.org\/10.1016\/j.jhep.2011.08.018 PMID: 22023985","journal-title":"Hepatol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhep.2012.01.028","volume":"57(2)","author":"Li,Y.","year":"2012","unstructured":"Li,Y.; Chen, D. The optimal dose of omega-3 supplemen-tation for non-alcoholic fatty liver disease, J. Hepatol. 2012,57(2),468-469. http:\/\/dx.doi.org\/10.1016\/j.jhep.2012.01.028 PMID: 22433603","journal-title":"Hepatol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(99) 07072-5","volume":"354(9177)","year":"1999","unstructured":"GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet. 1999,354(9177),447-455. http:\/\/dx.doi.org\/10.1016\/S0140-6736(99) 07072-5 PMID: 10465168","journal-title":"Lancet"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0140-6736(10) 60445-X","volume":"376(9740)","author":"Saravanan,P.","year":"2010","unstructured":"Saravanan,P.; Davidson, N.C.; Schmidt, E.B.; Calder, P.C. Cardiovascular effects of marine omega-3 fatty acids. Lan-cet. 2010,376(9740),540-550. http:\/\/dx.doi.org\/10.1016\/S0140-6736(10) 60445-X PMID: 20638121","journal-title":"Lan-cet"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.clnu.2011.12.007","volume":"31(4)","author":"Petit, J.M.","year":"2012","unstructured":"Petit, J.M.; Guiu,B.; Duvillard,L.; Jooste,V.; Brindisi, M.C.; Athias,A.; Bouillet,B.; Habchi,M.; Cottet,V.; Gambert,P.; Hillon,P.; Cercueil, J.P.; Verges, B. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is sig-nificantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. Clin. Nutr. 2012,31(4),520-525. http:\/\/dx.doi.org\/10.1016\/j.clnu.2011.12.007 PMID: 22209679","journal-title":"Clin.Nutr"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.27289","volume":"60(4)","author":"Scorletti,E.","year":"2014","unstructured":"Scorletti,E.; Bhatia,L.; McCormick, K.G.; Clough, G.F.; Nash,K.; Hodson,L.; Moyses, H.E.; Calder, P.C.; Byrne, C.D. WELCOME Study. Effects of purified eicosapen-taenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the welcome* study. Hepatology. 2014,60(4),1211-1221. http:\/\/dx.doi.org\/10.1002\/hep.27289 PMID: 25043514","journal-title":"Hepatology"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"7008","DOI":"10.3748\/wjg.v21.i22.7008","volume":"21(22)","author":"Li, Y.H.","year":"2015","unstructured":"Li, Y.H.; Yang, L.H.; Sha, K.H.; Liu, T.G.; Zhang, L.G.; Liu, X.X. Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. World J. Gas-troenterol. 2015,21(22),7008-7013. http:\/\/dx.doi.org\/10.3748\/wjg.v21.i22.7008 PMID: 26078579","journal-title":"World J.Gas-troenterol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.numecd.2012.10.010","volume":"23(11)","author":"Nobili,V.","year":"2013","unstructured":"Nobili,V.; Alisi,A.; Della Corte,C.; Ris\u00e9, P.; Galli,C.; Agostoni,C.; Bedogni, G. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in chil-dren. Nutr. Metab. Cardiovasc. Dis. 2013,23(11),1066-1070. http:\/\/dx.doi.org\/10.1016\/j.numecd.2012.10.010 PMID: 23220074","journal-title":"Nutr.Metab.Cardiovasc.Dis"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.nut.2014.03.020","volume":"30(11-12)","author":"Rahmawaty,S.","year":"2014","unstructured":"Rahmawaty,S.; Lyons-Wall,P.; Charlton,K.; Batterham,M.; Meyer, B.J. Effect of replacing bread, egg, milk, and yogurt with equivalent ?-3 enriched foods on ?-3 LCPUFA intake of Australian children. Nutrition. 2014,30(11-12),1337-1343. http:\/\/dx.doi.org\/10.1016\/j.nut.2014.03.020 PMID: 25280409","journal-title":"Nutrition"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.nut.2011.01.004","volume":"27(11-12)","author":"Meyer, B.J.","year":"2011","unstructured":"Meyer, B.J.; Kolanu, N. Australian children are not con-suming enough long-chain omega-3 polyunsaturated fatty acids for optimal health. Nutrition. 2011,27(11-12),1136-1140. http:\/\/dx.doi.org\/10.1016\/j.nut.2011.01.004 PMID: 21658909","journal-title":"Nutrition"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jpeds.2015.01.056","volume":"166(6)","author":"Janczyk,W.","year":"2015","unstructured":"Janczyk,W.; Lebensztejn,D.; Wierzbicka-Rucinska,A.; Mazur,A.; Neuhoff-Murawska,J.; Matusik,P.; Socha, P. Omega-3 fatty acids therapy in children with nonalcoholic fatty liver disease: a randomized controlled trial. J Pediatr. 2015,166(6),1358-1363.e1-3. https:\/\/dx.doi.org\/10.1016\/j.jpeds.2015.01.056 PMID: 25771388","journal-title":"J Pediatr"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","volume":"62(1)","author":"Argo, C.K.","year":"2015","unstructured":"Argo, C.K.; Patrie, J.T.; Lackner,C.; Henry, T.D.; de Lange, E.E.; Weltman, A.L.; Shah, N.L.; Al-Osaimi, A.M.; Pramoonjago,P.; Jayakumar,S.; Binder, L.P.; Simmons-Egolf, W.D.; Burks, S.G.; Bao,Y.; Taylor, A.G.; Rodri-guez,J.; Caldwell, S.H. Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, ran-domized, placebo-controlled trial, J. Hepatol. 2015,62(1),190-197. http:\/\/dx.doi.org\/10.1016\/j.jhep.2014.08.036 PMID: 25195547","journal-title":"Hepatol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MCG.0000000000000099","volume":"49(2)","author":"Dasarathy,S.","year":"2015","unstructured":"Dasarathy,S.; Dasarathy,J.; Khiyami,A.; Yerian,L.; Hawkins,C.; Sargent,R.; McCullough, A.J. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonal-coholic steatohepatitis, J. Clin. Gastroenterol. 2015,49(2),137-144. http:\/\/dx.doi.org\/10.1097\/MCG.0000000000000099 PMID: 24583757","journal-title":"Clin.Gastroenterol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","volume":"147(2)","author":"Sanyal, A.J.","year":"2014","unstructured":"Sanyal, A.J.; Abdelmalek, M.F.; Suzuki,A.; Cummings, O.W.; Chojkier, M. EPE-a study group. No significant ef-fects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroen-terology. 2014,147(2),377-384.e1. http:\/\/dx.doi.org\/10.1053\/j.gastro.2014.04.046 PMID: 24818764","journal-title":"Gastroen-terology"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.3748\/wjg.v18.i41.5839","volume":"18(41)","author":"Di,Minno.","year":"2012","unstructured":"Di Minno, M.N.; Russolillo,A.; Lupo-li,R.; Ambrosino,P.; Di Minno,A.; Tarantino, G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J. Gastroenterol. 2012,18(41),5839-5847. http:\/\/dx.doi.org\/10.3748\/wjg.v18.i41.5839 PMID: 23139599","journal-title":"World J.Gastroenterol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","volume":"181","author":"Jump, D.B.","year":"2018","unstructured":"Jump, D.B.; Lytle, K.A.; Depner, C.M.; Tripathy, S. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacol. Ther. 2018,181,108-125. http:\/\/dx.doi.org\/10.1016\/j.pharmthera.2017.07.007 PMID: 28723414","journal-title":"Pharmacol.Ther"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","volume":"64","author":"Scorletti,E.","year":"2018","unstructured":"Scorletti,E.; Byrne, C.D. Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action. Mol. Aspects Med. 2018,64,135-146. https:\/\/dx.doi.org\/10.1016\/j.mam.2018.03.001 PMID: 29544992","journal-title":"Mol.Aspects Med"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"e0162368.","DOI":"10.1371\/journal.pone.0162368","volume":"11(10)","author":"He, X.X.","year":"2016","unstructured":"He, X.X.; Wu, X.L.; Chen, R.P.; Chen,C.; Liu, X.G.; Wu, B.J.; Huang, Z.M. Effectiveness of omega-3 polyunsatu-rated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLoS One. 2016,11(10),e0162368. http:\/\/dx.doi.org\/10.1371\/journal.pone.0162368 PMID: 27711128","journal-title":"PLoS One"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15(6)","author":"Schuster,S.","year":"2018","unstructured":"Schuster,S.; Cabrera,D.; Arrese,M.; Feldstein, A.E. Trig-gering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol. 2018,15(6),349-364. http:\/\/dx.doi.org\/10.1038\/s41575-018-0009-6 PMID: 29740166","journal-title":"Nat.Rev.Gastroenterol.Hepatol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1152\/ajpendo.00366.2014","volume":"308(2)","author":"Chen,G.","year":"2015","unstructured":"Chen,G.; Xu,R.; Zhang,S.; Wang,Y.; Wang,P.; Edin, M.L.; Zeldin, D.C.; Wang, D.W. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Am, J. Physiol. Endocrinol. Metab. 2015,308(2),E97-E110. http:\/\/dx.doi.org\/10.1152\/ajpendo.00366.2014 PMID: 25389366","journal-title":"Am, J.Physiol.Endocrinol.Metab"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"e110162.","DOI":"10.1371\/journal.pone.0110162","volume":"9(10)","author":"Schuck, R.N.","year":"2014","unstructured":"Schuck, R.N.; Zha,W.; Edin, M.L.; Gruzdev,A.; Vendrov, K.C.; Miller, T.M.; Xu,Z.; Lih, F.B.; DeGraff, L.M.; Tomer, K.B.; Jones, H.M.; Makowski,L.; Huang,L.; Poloyac, S.M.; Zeldin, D.C.; Lee, C.R. The cytochrome P450 epoxygenase pathway regulates the hepatic inflam-matory response in fatty liver disease. PLoS One. 2014,9(10),e110162. http:\/\/dx.doi.org\/10.1371\/journal.pone.0110162 PMID: 25310404","journal-title":"PLoS One"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.phrs.2017.12.013","volume":"132","author":"Valenzuela,R.","year":"2018","unstructured":"Valenzuela,R.; Videla, L.A. Crosstalk mechanisms in he-patoprotection: thyroid hormone-docosahexaenoic acid (DHA)  and DHA-extra virgin olive oil combined protocols. Pharmacol. Res. 2018,132,168-175. http:\/\/dx.doi.org\/10.1016\/j.phrs.2017.12.013 PMID: 29253525","journal-title":"Pharmacol.Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/ars.2016.6776","volume":"26(10)","author":"Spahis,S.","year":"2017","unstructured":"Spahis,S.; Delvin,E.; Borys, J.M.; Levy, E. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid. Redox Signal. 2017,26(10),519-541. http:\/\/dx.doi.org\/10.1089\/ars.2016.6776 PMID: 27452109","journal-title":"Antioxid.Redox Signal"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"9547613.","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"Masarone,M.","year":"2018","unstructured":"Masarone,M.; Rosato,V.; Dallio,M.; Gravina, A.G.; Aglitti,A.; Loguercio,C.; Federico,A.; Persico, M. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid. Med. Cell. Longev. 2018,2018,9547613. http:\/\/dx.doi.org\/10.1155\/2018\/9547613 PMID: 29991976","journal-title":"Oxid.Med.Cell.Longev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/171505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/171505\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/171505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:24:26Z","timestamp":1613838266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/171505\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":152,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2020,9,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190410121716","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}